The US aesthetic device market is witnessing robust growth driven by technological advancements, the rising popularity of non-invasive cosmetic procedures, and a growing aging population with a heightened interest in appearance enhancement. The market was valued at USD 8,350 million in 2025 and is projected to reach USD 22,700 million by 2035, growing at a CAGR of 9.7% from 2024 to 2035.
The economic impact of tariffs on "US Aesthetic Device".
US Aesthetic Device Market Growth Drivers
Technological Advancements in Non-Invasive Devices: The US aesthetic device market is propelled by continuous advancements in non-invasive technologies, such as laser, radiofrequency, and ultrasound-based devices. Companies like Cynosure (a division of Cynosure, Inc.) have introduced innovative platforms such as the Elite iQ that provide customizable treatments with improved safety and minimal downtime. These technological improvements have significantly boosted patient confidence and satisfaction, resulting in higher adoption rates among both practitioners and consumers.
Rising Demand for Anti-Aging Solutions: There is an increasing demand for anti-aging procedures and products, driven by a growing aging population and a desire to maintain youthfulness. Allergan Aesthetics (an AbbVie company) has seen increased utilization of its CoolSculpting Elite and Juvéderm products in US clinics. Aging demographics, coupled with improved accessibility to aesthetic treatments, are likely to continue driving growth in this sector through the forecast period.
US Aesthetic Device Market Trends
Popularity of Home-Use Aesthetic Devices: Consumer interest in home-use aesthetic devices is on the rise, fueled by convenience, cost savings, and the impact of telehealth trends post-pandemic. Companies such as NuFACE offer FDA-cleared microcurrent technology for home use, allowing consumers to achieve some professional results without visiting clinics. This trend is resulting in new market segments and expanding revenue streams for device manufacturers.
Expansion of Combination Treatments: Medical professionals are increasingly combining different aesthetic technologies to achieve superior results. Syneron Candela’s Nordlys system, for example, integrates intense pulsed light (IPL), Frax, and Nd:YAG technologies for multi-application versatility. This trend addresses patient demand for tailored and comprehensive procedures, encouraging an uptick in aesthetic device investments by clinics.
US Aesthetic Device Market Opportunity
Untapped Male Aesthetics Segment: The emerging focus on male aesthetics, with companies like Cutera launching targeted marketing and device applications for men, presents significant untapped opportunities. Increasing acceptance of aesthetic treatments among men is expected to unlock new revenue streams.
Integration of Artificial Intelligence (AI): There is a substantial opportunity in leveraging AI for personalized treatment recommendations and predictive analytics. Companies incorporating AI, such as Lumenis with its AI-driven solutions for patient assessment, are positioned to capture market share by enhancing treatment outcomes and clinic efficiency.
US Aesthetic Device Market Revenue (USD Million), 2020-2035
The accompanying chart illustrates the projected growth of the US aesthetic device market from 2020 to 2035. In 2020, the market was estimated at USD 5,150 million and saw steady growth year-over-year. Key drivers include technological innovation, broader accessibility, and societal acceptance of aesthetic procedures. By 2025, the market reached an estimated USD 8,350 million, and by 2035, it is expected to achieve USD 22,700 million, displaying a clear upward trajectory due to increasing adoption across diverse demographic segments and expanding applications of devices. The chart highlights the market’s resilience and strong compound annual growth rate of roughly 9.7%.
US Aesthetic Device Market by Region Share (%), 2025
The pie chart for 2025 demonstrates the regional distribution of aesthetic device market share across the United States. The West holds the largest share at 34%, attributed to higher urban populations and a concentration of premium cosmetic clinics in states like California. The South follows with 27%, benefitting from expanding cosmetic chains and a rise in minimally invasive procedures. The Northeast contributes 18% due to established urban centers and affluent populations, while the Midwest accounts for 13%, showing a steady uptake in non-invasive technologies. The Southwest constitutes 8%, reflecting emerging demand in metropolitan hubs. This distribution mirrors economic variations, clinic density, and demographic factors influencing the popularity of aesthetic devices regionally.
US Aesthetic Device Recent Developments (Last 6 Months)
In May 2024, Allergan Aesthetics (AbbVie) announced the FDA clearance and launch of its new CoolSculpting Pro system, which features improved fat reduction capabilities and enhanced patient comfort. The device incorporates AI-powered sensors to personalize treatments, addressing the growing demand for minimally invasive body contouring solutions.
In March 2024, Cutera unveiled its truSculpt flex+ device, designed for faster, safer, and more customizable muscle sculpting procedures. The new system offers reduced treatment time and increased muscle engagement, making it attractive for both practitioners and clients seeking efficient, non-surgical body shaping.
In April 2024, Lumenis introduced its Stellar M22 platform which integrates AI for patient skin analysis and device parameter optimization. This move represents a significant step towards personalized, outcome-driven aesthetic treatments and positions Lumenis at the forefront of next-generation aesthetic device technology in the US market.
Press Releases